Company news
AdAlta Ltd. news in 2017
AdAlta Ltd.'s news releases, calls and decks from 2017, newest first.
AdAlta collaborator awarded NHMRC grant
December 6, 2017
AdAlta granted key Australian Patent
November 16, 2017
Commercial agreement with XL-protein
November 13, 2017
Conference Presentation
October 31, 2017
Results of multi-dose toxicology study
September 18, 2017
AdAlta awarded SIEF grant
July 23, 2017
Toxicology study and manufacturing update
July 17, 2017
Presentation of Eye Fobrosis Data at ARVO Meeting
May 8, 2017
AdAlta expands partnership with Alfred Hospital
March 20, 2017
AdAlta receives Orphan Designation for AD-114
January 18, 2017
Positive Pre-clinical Data
January 8, 2017
Decks in 2017
- Shareholder Meeting (November 2017)
Shareholder meeting · 18 slides · Nov 14, 2017
- Anti-Fibrotic Drug Development Summit, Boston, 2017
Conference · 40 slides · Nov 13, 2017
- AusBiotech 2017
Conference · 14 slides · Oct 23, 2017
- Australian and New Zealand Society of Nephrology Annual Scientific Meeting 2017
Conference · 19 slides · Sep 4, 2017
- IPF Summit 2017
Conference · 27 slides · Aug 21, 2017
- Bioshares Biotech Summit 2017
Conference · 28 slides · Jul 21, 2017
- Investor Presentation (May 2017)
Investor deck · 19 slides · May 3, 2017
- Investor Day (February 2017)
Investor day · 127 slides · Feb 21, 2017
- Investor Day (February 2017)
Investor day · 125 slides · February 2017
- Investor Presentation (January 2017)
Investor deck · 26 slides · Jan 17, 2017